Document is current

Any future updates will be listed below

Harnessing local and system immune profiling delineating differential responders to first-line sintilimab (anti-PD-1 antibody) combined with chemotherapy in extensive-stage small cell lung cancer: an exploratory biomarker analysis of a phase II study

Crossref DOI link: https://doi.org/10.1038/s41392-025-02252-5

Published Online: 2025-05-23

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark